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Transient beneﬁ ts in young children of a nutrition 
intervention during pregnancy
In this issue of The Lancet Global Health, Delan 
Devakumar and colleagues1 report on the follow-up 
of children aged 8·5 years in southern Nepal whose 
mothers participated in a randomised controlled trial 
of multiple micronutrient supplementation during 
pregnancy. Control mothers received standard doses 
of iron and folic acid supplements. The oﬀ spring of 
mothers in the intervention group had signiﬁ cantly 
higher birthweights and higher weights and lower 
systolic blood pressures at age 2·5 years than the 
oﬀ spring of control mothers. However, at age 8·5 years, 
no diﬀ erence was detected in weight-for-age, height-
for-age, body-mass-index-for-age, and systolic blood 
pressure. This ﬁ nding is consistent with those of other 
studies cited by Devakumar and colleagues in Burkina 
Faso, China, and Bangladesh.
The ﬁ ndings add to the mosaic of evidence on the 
eﬀ ectiveness of interventions to prevent child under-
nutrition. Multiple micronutrient supplements during 
pregnancy were recommended in The Lancet’s Series 
on maternal and child nutrition in June, 2013, in 
which a meta-analysis was cited that found that such 
supplements led to a 12% reduction in intrauterine 
growth restriction.2
What might explain the ﬁ ndings that the beneﬁ ts of 
the intervention at birth and early childhood were no 
longer apparent in mid-childhood? There was 30% loss 
to follow-up between enrolment in the randomised 
controlled trial and 8·5 years. Although lost children 
were more likely to be urban and their mothers 
more educated, there was no diﬀ erence between the 
intervention and control groups. The use of diﬀ erent 
reference populations at 2·5 and 8·5 years might have 
aﬀ ected the values of anthropometric indices. Perhaps 
Devakumar and colleagues could reanalyse the data 
at 2·5 years using the most recent WHO reference 
population to determine whether the convergent trend 
stands. Finally, the follow-up study was not powered to 
detect diﬀ erences in weight of less than 800g; however, 
as Devakumar and colleagues point out, the clinical 
signiﬁ cance of lower diﬀ erences is uncertain.
The slower growth velocity in the intervention 
children between ages 2·5 and 8·5 years might be due to 
environmental inﬂ uences that have not been identiﬁ ed 
in this study, such as child feeding practices or other 
family-based lifestyle factors, which could be clustered 
by com munity. This potential clustering eﬀ ect of 
nutrition behaviours was not analysed in the study.
Another possibility lies in the fact that growth rates 
are relatively slow in pre-adolescent children and 
diﬀ erences between the intervention and control 
groups could re-emerge during the adolescent growth 
spurt. This possibility suggests the need for further 
follow-up during early adolescence.
Do the ﬁ ndings of this study call for a review of 
current recommendations? Certainly not, given that a 
number of randomised controlled trials have shown that 
multiple micronutrient supplements in pregnancy are 
associated with reduced rates of low birthweight,3 and 
low birthweight is a strong predictor of child survival. A 
study in Indonesia4 found that multiple micronutrient 
supplements in a large sample of pregnant women led 
to an 18% reduction in early infant mortality compared 
with infants of women given iron and folic acid.
But this study does challenge some of the assumptions 
underlying the current global focus on nutrition 
inter ventions during the “ﬁ rst 1000 days” between 
conception and a child’s second birthday.5 Although 
the evidence to support this approach remains solid, 
Devakumar and colleagues’ paper suggests that there 
is a need to look at continuing nutritional support into 
childhood and adolescence. Studies that can pinpoint 
other factors, beyond dietary behaviours and biological 
markers, that aﬀ ect children’s growth velocity into 
adolescence are urgently needed.
The paper also challenges us to re-evaluate the 
assumptions underlying the “Barker hypothesis”—that 
babies who have a low birthweight are at greater risk 
of developing cardiovascular disease in adulthood.6 
The ﬁ nding that there was no diﬀ erence in systolic 
blood pressure between the intervention group and the 
control group suggests that other factors, not measured 
by the study, might be at play. A signiﬁ cant number of 
girls aged 8–11 years will have experienced puberty. So 
one would expect that those who initially beneﬁ ted 
as a result of the intervention might experience 
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some rebound at this age.7 Further follow-up of these 
Nepalese children in adolescence could shed more light 
on this issue.
*Michael J Toole, Andre Renzaho
Burnet Institute, Melbourne, VIC 3184, Australia (MJT, AR); 
Department of Epidemiology and Preventive Medicine, Monash 
University, Melbourne, VIC, Australia (MJT, AR); and School of 
Social Sciences and Psychology, University of Western Sydney, 
Sydney, NSW, Australia (AR)
toole@burnet.edu.au
We declare no competing interests.
© Copyright Toole at al. This is an open access article published under the terms 
of CC BY-NC-SA.
1 Devakumar D, Chaube SS, Wells JCK, et al. Eﬀ ect of antenatal multiple 
micronutrient supplementation on anthropometry and blood pressure in 
mid-childhood in Nepal: follow-up of a double-blind randomised 
controlled trial. Lancet Glob Health 2014; 2: e654–63.
2 Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for 
improvement of maternal and child nutrition: what can be done and at 
what cost? Lancet 2013; 382: 452–77.
3 Ramakrishnan U, Grant FK, Goldenberg T, Bui V, Imdad A, Bhutta ZA. Eﬀ ect 
of multiple micronutrient supplementation on pregnancy and infant 
outcomes: a systematic review. Paediatr Perinat Epidemiol 2012; 
26(suppl 1): 153–67.
4 Supplementation with Multiple Micronutrients Intervention Trial 
(SUMMIT) Study Group. Eﬀ ect of maternal multiple micronutrient 
supplementation on fetal loss and infant death in Indonesia: 
a double-blind cluster-randomised trial. Lancet 2008; 371: 215–27.
5 The Lancet. Executive Summary of The Lancet Maternal and Child Nutrition 
Series. http://download.thelancet.com/ﬂ atcontentassets/pdfs/nutrition-
eng.pdf (accessed Oct 6, 2014).
6 Barker DJP. Fetal origins of coronary heart disease. BMJ 1995; 311: 171.
7 Veldhuis JD, Roemmich JN, Richmond EJ, et al. Endocrine control of body 
composition in infancy, childhood, and puberty. Endocrine Rev 2005; 
26: 114–46.
